9/24/2013

Pakistan's Supreme Court notified 22 pharmaceutical firms that they had sold drugs at prices higher than allowed by the country's Drug Regulatory Authority. Highnoon Laboratories, Epla Laboratories, Pharmatec Pakistan, Roche Pakistan and W. Woodward are among the companies named.

Related Summaries